Nuvectis Pharma Stock Price on January 3, 2023
| NVCT Stock | USD 5.04 0.24 4.55% |
If you're considering investing in Nuvectis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Nuvectis Pharma stands at 5.04, as last reported on the 29th of November, with the highest price reaching 5.48 and the lowest price hitting 4.99 during the day. Nuvectis Pharma has Sharpe Ratio of -0.0043, which conveys that the firm had a -0.0043% return per unit of risk over the last 3 months. Nuvectis Pharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nuvectis Pharma's Risk Adjusted Performance of 0.0089, mean deviation of 4.37, and Standard Deviation of 8.45 to check out the risk estimate we provide.
At this time, Nuvectis Pharma's Total Stockholder Equity is comparatively stable compared to the past year. Common Stock is likely to gain to about 17.9 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 14.8 M in 2024. . At this time, Nuvectis Pharma's Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 1.81 in 2024, despite the fact that Price To Operating Cash Flows Ratio is likely to grow to (7.73). Nuvectis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Nuvectis |
Sharpe Ratio = -0.0043
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NVCT |
Estimated Market Risk
| 8.58 actual daily | 76 76% of assets are less volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nuvectis Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nuvectis Pharma by adding Nuvectis Pharma to a well-diversified portfolio.
Price Book 9.2817 | Book Value 0.579 | Enterprise Value 84.8 M | Enterprise Value Ebitda (7.38) | Shares Float 6.8 M |
Nuvectis Pharma Valuation on January 3, 2023
It is possible to determine the worth of Nuvectis Pharma on a given historical date. On January 3, 2023 Nuvectis was worth 7.5 at the beginning of the trading date compared to the closed value of 7.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Nuvectis Pharma stock. Still, in general, we apply an absolute valuation method to find Nuvectis Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nuvectis Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Nuvectis Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 7.28 | 7.72 | 7.21 | 7.50 | 37,758 | |
01/03/2023 | 7.50 | 7.50 | 7.14 | 7.50 | 3,000 |
| 7.39 | 7.85 | 7.39 | 7.49 | 61,982 |
| Backtest Nuvectis Pharma | | | Nuvectis Pharma History | | | Nuvectis Pharma Valuation | Previous | Next |
Nuvectis Pharma Trading Date Momentum on January 3, 2023
| On January 04 2023 Nuvectis Pharma was traded for 7.49 at the closing time. The top price for the day was 7.85 and the lowest listed price was 7.39 . The trading volume for the day was 62 K. The trading history from January 4, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.13% . The trading delta at closing time against the current closing price is 4.80% . |
Nuvectis Pharma Fundamentals Correlations and Trends
By evaluating Nuvectis Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Nuvectis Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Nuvectis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Nuvectis Pharma Stock history
Nuvectis Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Nuvectis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Nuvectis Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Nuvectis Pharma stock prices may prove useful in developing a viable investing in Nuvectis Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 15.6 M | 14.8 M | |
| Net Loss | -17.2 M | -16.3 M |
Nuvectis Pharma Quarterly Net Working Capital |
|
Nuvectis Pharma Stock Technical Analysis
Nuvectis Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Nuvectis Pharma Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Nuvectis Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Nuvectis Pharma November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Nuvectis Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nuvectis Pharma shares will generate the highest return on investment. By undertsting and applying Nuvectis Pharma stock market strength indicators, traders can identify Nuvectis Pharma entry and exit signals to maximize returns
Nuvectis Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Nuvectis Pharma's price direction in advance. Along with the technical and fundamental analysis of Nuvectis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Nuvectis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0089 | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (1.28) | |||
| Treynor Ratio | (0) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Nuvectis Stock Analysis
When running Nuvectis Pharma's price analysis, check to measure Nuvectis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvectis Pharma is operating at the current time. Most of Nuvectis Pharma's value examination focuses on studying past and present price action to predict the probability of Nuvectis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvectis Pharma's price. Additionally, you may evaluate how the addition of Nuvectis Pharma to your portfolios can decrease your overall portfolio volatility.